Vascular Embolization Market Growth Projection: Expected to Surpass $5.41 Billion by 2030 at 9.9% CAGR
Uncover key drivers, emerging technologies, and competitive movements shaping the vascular embolization market from 2026–2035 with trusted insights from The Business Research Company
How much larger will the Vascular Embolization Market be in 2030 compared with 2026?
The size of the vascular embolization market has experienced robust growth in recent years. This market is projected to expand from $3.39 billion in 2025 to $3.71 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.4%. Historically, this growth can be attributed to several factors, including the expansion of interventional radiology practices, the increasing prevalence of vascular disorders, a rise in cancer treatment procedures, enhanced access to catheter-based technologies, and growing physician expertise in embolization.
The vascular embolization market size is projected to undergo significant expansion in the upcoming years, with its value expected to reach $5.41 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.9%. This growth throughout the forecast period stems from factors such as increasing demand for targeted therapies, rising investments in interventional oncology, the expansion of outpatient embolization procedures, the growing adoption of advanced imaging integration, and an increasing focus on patient-centric treatment options. Prominent trends anticipated in the forecast period include the increasing adoption of minimally invasive embolization procedures, a rising use of advanced embolic materials, growing demand for image-guided interventions, the expansion of oncology-related embolization applications, and an enhanced emphasis on procedure precision and safety.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12660&type=smp
What Drivers Are Guiding Growth Patterns In The Vascular Embolization Market?
The rising incidence of chronic kidney diseases is anticipated to drive the expansion of the vascular embolization market moving ahead. Chronic Kidney Disease (CKD) describes a condition where the kidneys sustain progressive and irreversible damage over a period. In the context of chronic kidney disease (CKD), vascular embolization offers a method to halt hemorrhage from renal tumors, arteriovenous malformations (AVMs), or issues arising from kidney biopsies or transplants, thereby eliminating the need for open surgery and its inherent dangers, especially for individuals with impaired kidney function. A notable example is data from June 2023 by ZS Associates, a UK-based Kidney Research Commission, which indicated that kidney disease in the UK is projected to impact 7.19 million individuals in 2023, representing over 10% of the populace. This figure is predicted to climb to 7.61 million by 2033, with the percentage of patients in advanced stages of the illness growing from 45% to 51%. Consequently, the widespread occurrence of chronic kidney diseases is fueling the expansion of the vascular embolization market.
Which Segments Are Driving Activity In The Vascular Embolization Market?
The vascular embolization market covered in this report is segmented –
1) By Product: Embolic Agents, Embolization Devices
2) By Embolization Technique: Coiling Devices, Non-Coiling Devices
3) By Application: Peripheral Vascular Diseases, Oncology, Urology, Neurology, Other Applications
4) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers
Subsegments:
1) By Embolic Agents: Particle Embolic Agents, Liquid Embolic Agents, Coil Embolic Agents, Gelatin Sponge Embolic Agents
2) By Embolization Devices: Balloon Occlusion Devices, Catheters, Thrombin Injection Systems
What Trends Are Expected To Impact The Competitive Landscape Of The Vascular Embolization Market?
Leading companies operating in the vascular embolization market are actively developing innovative products, such as embolic systems, to enhance their market profitability. An embolic system refers to the combination of embolic agents and delivery devices designed to intentionally block blood vessels. Vascular embolization is a medical procedure in which these embolic systems are employed to occlude or reduce blood flow to specific areas of the body. For instance, in October 2023, Sirtex Medical, a US-based medical device company, launched the Lava liquid embolic system (LES). Lava, with its 2-mL and 6-mL volume options, offers a versatile solution for controlled target vessel occlusion within the peripheral vasculature. Its varied viscosity options enable effective distal embolization, particularly for small, hard-to-reach vessels. The FDA approved the Lava LES based on its safety and efficacy demonstrated in the single-arm LAVA Study, a prospective, multicenter trial evaluating acute peripheral arterial hemorrhages.
Which Major Industry Participants Are Leading The Vascular Embolization Market Growth?
Major companies operating in the vascular embolization market are Abbott Laboratories, Medtronic Plc., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Kaneka Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Teleflex Inc., Cook Group Incorporated, Merit Medical Systems Inc., Penumbra Inc., MicroPort Scientific Corporation, MicroVention Inc., Medikit Co Ltd., Silk Road Medical Inc., Galt Medical Corporation, Neuravi Ltd., Phenox GmbH, Spartan Micro Inc., EndoShape Inc., Shape Memory Medical Inc., Balt Group, Vascular Solutions Inc.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report
Which Region Is Projected To Lead The Vascular Embolization Market During The Forecast Period?
North America was the largest region in the vascular embolization market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular embolization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Vascular Embolization Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12660&type=smp
Browse Through More Reports Similar to the Global Vascular Embolization Market 2026, By The Business Research Company
Transcatheter Embolization And Occlusion Devices Market Report 2026
Pulmonary Embolism Market Report 2026
https://www.thebusinessresearchcompany.com/report/pulmonary-embolism-global-market-report
Neurovascular Embolization Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
